Bodick Neil 4
4 · Flexion Therapeutics Inc · Filed Nov 22, 2017
Insider Transaction Report
Form 4
Bodick Neil
Chief Medical Officer
Transactions
- Purchase
Common Stock
2017-11-21$24.39/sh+1,700$41,457→ 64,605 total - Purchase
Common Stock
2017-11-21$24.66/sh+1,000$24,656→ 1,000 total(indirect: By Spouse)
Holdings
- 388,683(indirect: By LLC)
Common Stock
Footnotes (1)
- [F1]Shares held by Versant Development Fund III, LLC. The Reporting Person is a manager and minority member of Versant Development Fund III, LLC. The Reporting Person disclaims any beneficial ownership of the shares held by Versant Development Fund III, LLC except to the extent of his pecuniary interest in these shares.